Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
To demonstrate the bioequivalence of 500 mg and 1000 mg Glucophage tablets manufactured by
BMS relative to the respective strengths of 500 mg and 1000 mg Diabex tablets marketed in
Australia by Alphapharm in the fed state